David Patrick Lee, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G79800 · Current
Licensed to practise in California · since 1994 · expires 2028-01-31 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$111,764
Medicare paid this office $111,764 for 365 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 133 | $23,697 | $176 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 40 | $22,278 | $420 |
| Short return visit (20+ min) | 43 | $5,568 | $80 |
| Biopsy of heart muscle | 17 | $4,787 | $184 |
| Return visit (30+ min) | 23 | $3,878 | $114 |
See all 12 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 133 | $23,697 | $176 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 40 | $22,278 | $420 |
| Short return visit (20+ min) | 43 | $5,568 | $80 |
| Biopsy of heart muscle | 17 | $4,787 | $184 |
| Return visit (30+ min) | 23 | $3,878 | $114 |
| Return visit (30+ min) | 44 | $3,779 | $77 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $3,612 | $241 |
| Short return visit (20+ min) | 48 | $2,831 | $52 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 16 | $2,459 | $154 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 29 | $2,363 | $79 |
| Insertion of tube in right heart chambers for measurement | 20 | $2,200 | $105 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 192 | $2,131 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 76 | More than 92% of doctors who do this |
Who their Medicare patients are
365 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 13% · Women 36% · Also on Medicaid 26% · Health risk score 2.07. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 74% · Heart failure 48% · Atrial fibrillation 43% · Diabetes 42% · Chronic kidney disease 42% · COPD 24% · Depression 22% · Cancer 20% · Stroke 16% · Dementia 11%.
The office billed $1,494,852, Medicare allowed $143,548 and paid $111,764; for 821 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 365 | 821 | 74 | 2.07 | $1,494,852 | $111,764 |
| 2023 | 378 | 870 | 74 | 2.08 | $1,396,510 | $111,605 |
| 2022 | 373 | 828 | 74 | 2.20 | $1,266,814 | $112,777 |
| 2021 | 373 | 893 | 73 | 1.85 | $1,343,554 | $126,263 |
| 2020 | 439 | 806 | 72 | 2.23 | $1,044,174 | $95,460 |
| 2019 | 436 | 889 | 74 | 2.16 | $917,283 | $116,624 |
| 2018 | 423 | 886 | 72 | 2.06 | $804,897 | $127,827 |
| 2017 | 322 | 683 | 74 | 1.95 | $577,872 | $100,177 |
| 2016 | 402 | 715 | 73 | 1.94 | $744,689 | $127,256 |
| 2015 | 354 | 666 | 73 | 1.97 | $647,986 | $96,571 |
| 2014 | 382 | 710 | 72 | 1.54 | $681,016 | $96,070 |
| 2013 | 858 | 1,404 | 72 | 1.92 | $512,396 | $75,169 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 137 | $24,750 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 33 | $17,154 | $451 |
| Short return visit (20+ min) | 102 | $9,032 | $55 |
| Biopsy of heart muscle | 25 | $5,653 | $177 |
| Return visit (30+ min) | 45 | $5,239 | $89 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $5,044 | $240 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 19 | $4,057 | $214 |
| Insertion of tube in right heart chambers for measurement | 20 | $2,079 | $104 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 21 | $1,707 | $81 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $936 | $62 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 166 | $800 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $593 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $497 | $45 |
2022: 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 43 | $24,694 | $449 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 107 | $18,570 | $170 |
| Biopsy of heart muscle | 32 | $8,846 | $188 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 29 | $7,240 | $250 |
| Return visit (30+ min) | 52 | $6,492 | $83 |
| Short return visit (20+ min) | 87 | $6,347 | $54 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $2,907 | $194 |
| Insertion of tube in right heart chambers for measurement | 19 | $2,235 | $112 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $1,901 | $83 |
| New patient visit (45+ min) | 15 | $1,618 | $108 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $948 | $63 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 188 | $938 | $5 |
2021: 14 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 126 | $23,082 | $182 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 40 | $21,590 | $450 |
| Return visit (30+ min) | 58 | $7,185 | $83 |
| Short return visit (20+ min) | 88 | $7,060 | $52 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 24 | $6,331 | $264 |
| Biopsy of heart muscle | 25 | $6,225 | $189 |
| Long return visit (40+ min) | 31 | $4,338 | $128 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 14 | $3,457 | $203 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 30 | $2,526 | $84 |
| Insertion of tube in right heart chambers for measurement | 17 | $1,944 | $108 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 153 | $1,801 | $11 |
| New patient visit (45+ min) | 14 | $1,695 | $121 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $709 | $64 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 38 | $190 | $5 |
2020: 13 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $19,427 | $474 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 93 | $16,566 | $176 |
| Biopsy of heart muscle | 23 | $5,869 | $196 |
| Short return visit (20+ min) | 114 | $5,661 | $38 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $5,171 | $259 |
| Return visit (30+ min) | 25 | $2,302 | $70 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,477 | $11 |
| New patient visit (30+ min) | 21 | $1,470 | $70 |
| Insertion of tube in right heart chambers for measurement | 13 | $1,425 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 123 | $1,133 | $8 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,112 | $86 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $793 | $66 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $332 | $24 |
2019: 14 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 123 | $23,322 | $187 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $16,834 | $481 |
| Repair of mitral valve through the skin, initial prosthesis | 11 | $16,806 | $1,528 |
| Short return visit (20+ min) | 144 | $8,633 | $41 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 32 | $7,946 | $248 |
| Biopsy of heart muscle | 28 | $6,606 | $174 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 17 | $3,824 | $212 |
| Insertion of tube in right heart chambers for measurement | 25 | $2,586 | $76 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 30 | $2,531 | $82 |
| Return visit (30+ min) | 26 | $1,866 | $72 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 155 | $1,763 | $11 |
| New patient visit (30+ min) | 23 | $1,428 | $62 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,306 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $439 | $8 |
2018: 14 services
| Repair of mitral valve through the skin, initial prosthesis | 17 | $25,756 | $1,515 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 117 | $21,121 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $17,240 | $466 |
| Biopsy of heart muscle | 33 | $9,121 | $175 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 36 | $8,873 | $246 |
| Short return visit (20+ min) | 129 | $6,947 | $38 |
| Insertion of tube in right heart chambers for measurement | 29 | $3,140 | $70 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 14 | $3,034 | $217 |
| Return visit (30+ min) | 39 | $2,826 | $69 |
| New patient visit (30+ min) | 41 | $2,787 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 170 | $1,956 | $11 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 23 | $1,841 | $80 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,156 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $121 | $7 |
2017: 11 services
| Repair of mitral valve through the skin, initial prosthesis | 17 | $28,146 | $1,564 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 55 | $10,325 | $184 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $10,242 | $466 |
| Short return visit (20+ min) | 147 | $9,491 | $40 |
| Biopsy of heart muscle | 24 | $4,838 | $173 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $4,337 | $255 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $3,155 | $210 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 128 | $1,495 | $11 |
| Insertion of tube in right heart chambers for measurement | 15 | $1,472 | $98 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,157 | $83 |
| New patient visit (15+ min) | 20 | $770 | $39 |
2016: 13 services
| Radiological supervision and interpretation of catheter-delivered implant (accessed through the skin) to left upper heart chamber for appendage closure | 14 | $23,133 | $1,652 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 84 | $17,318 | $199 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $14,347 | $448 |
| Short return visit (20+ min) | 161 | $9,690 | $39 |
| Biopsy of heart muscle | 23 | $8,698 | $185 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 27 | $7,343 | $272 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $3,170 | $211 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,817 | $83 |
| New patient visit (15+ min) | 44 | $1,761 | $40 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,151 | $82 |
| Hospital discharge day management, 30 minutes or less | 12 | $789 | $66 |
| New patient visit (30+ min) | 11 | $717 | $65 |
| Short return visit | 16 | $357 | $22 |
2015: 11 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $21,891 | $466 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 66 | $12,221 | $182 |
| Short return visit (20+ min) | 164 | $10,181 | $38 |
| Biopsy of heart muscle | 24 | $9,836 | $197 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 30 | $8,060 | $269 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 11 | $2,163 | $197 |
| New patient visit (30+ min) | 36 | $2,060 | $57 |
| Insertion of tube in right heart chambers for measurement | 18 | $2,055 | $89 |
| Return visit (30+ min) | 15 | $981 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $916 | $83 |
| Short return visit | 11 | $250 | $23 |
2014: 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 36 | $20,741 | $471 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 91 | $16,754 | $182 |
| Biopsy of heart muscle | 27 | $11,910 | $192 |
| Short return visit (20+ min) | 140 | $8,670 | $40 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $5,806 | $252 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 16 | $3,191 | $188 |
| Insertion of tube in right heart chambers for measurement | 19 | $2,133 | $97 |
| Short return visit | 53 | $1,190 | $20 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,114 | $80 |
| New patient visit (30+ min) | 13 | $878 | $68 |
| New patient visit (15+ min) | 23 | $851 | $37 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 35 | $845 | $24 |
2013: 13 services
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 40 | $10,799 | $263 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $10,567 | $480 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 63 | $10,397 | $165 |
| Short return visit (20+ min) | 135 | $7,516 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 488 | $4,719 | $6 |
| Biopsy of heart muscle | 19 | $4,620 | $171 |
| Return visit (30+ min) | 32 | $1,471 | $42 |
| New patient visit (15+ min) | 34 | $1,436 | $42 |
| New patient visit (30+ min) | 23 | $1,296 | $56 |
| Insertion of tube in right heart chambers for measurement | 13 | $1,283 | $92 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,157 | $77 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $889 | $21 |
| Short return visit | 22 | $473 | $21 |
Medicaid work
$912 in 2023
Medicaid paid $912 for 25 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 25 | $912 |
| 2023 | 25 | 1 | 13 | $912 |
| 2020 | 160 | 1 | 74 | $2,189 |
| 2019 | 34 | 1 | 31 | $320 |
See the largest Medicaid services in earlier years
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 160 | $2,189 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 34 | $320 |
Drugs they prescribed that Part D paid
$78,024
Pharmacies billed $78,024 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 766) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
708 generic and 58 brand-name prescriptions · $78,024 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Repatha Sureclick | 17 | $27,187 | $1,599 |
| Eliquis | 16 | $21,914 | $1,370 |
| Brilinta | 11 | $6,605 | $600 |
| Clopidogrel | 79 | $1,437 | $18 |
| Rosuvastatin | 62 | $1,249 | $20 |
See all 20 drugs
| Repatha Sureclick | 17 | $27,187 | $1,599 |
| Eliquis | 16 | $21,914 | $1,370 |
| Brilinta | 11 | $6,605 | $600 |
| Clopidogrel | 79 | $1,437 | $18 |
| Rosuvastatin | 62 | $1,249 | $20 |
| Ezetimibe | 24 | $842 | $35 |
| Atorvastatin | 94 | $748 | $8 |
| Isosorbide Mononitrate Er | 38 | $614 | $16 |
| Metoprolol | 25 | $535 | $21 |
| Nebivolol | 12 | $514 | $43 |
| Nitroglycerin | 20 | $294 | $15 |
| Losartan | 27 | $275 | $10 |
| Pravastatin | 18 | $191 | $11 |
| Carvedilol | 31 | $143 | $5 |
| Metoprolol | 17 | $138 | $8 |
| Amlodipine Besylate | 34 | $134 | $4 |
| Hydrochlorothiazide | 40 | $115 | $3 |
| Simvastatin | 12 | $108 | $9 |
| Lisinopril | 19 | $68 | $4 |
| Furosemide | 20 | $50 | $3 |
Year by year
| 2024 | 766 | 132 | 0% (0) | 8% | $78,024 |
| 2023 | 685 | 119 | 0% (0) | 7% | $68,039 |
| 2022 | 746 | 127 | 0% (0) | 4% | $52,699 |
| 2021 | 824 | 123 | None | 7% | $57,074 |
| 2020 | 813 | 125 | 0% (0) | 7% | $52,317 |
| 2019 | 739 | 133 | 0% (0) | 10% | $36,788 |
| 2018 | 693 | 143 | None | 8% | $37,341 |
| 2017 | 756 | 127 | None | 15% | $46,616 |
| 2016 | 1,010 | 173 | None | 14% | $57,074 |
| 2015 | 1,019 | 146 | None | 19% | $58,308 |
| 2014 | 879 | 140 | None | None | $53,887 |
| 2013 | 854 | 117 | None | 30% | $50,828 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Eliquis | 22 | $20,242 | $920 |
| Nebivolol | 18 | $1,925 | $107 |
| Rosuvastatin | 46 | $1,916 | $42 |
| Clopidogrel | 76 | $1,796 | $24 |
| Atorvastatin | 84 | $1,403 | $17 |
| Isosorbide Mononitrate Er | 28 | $1,147 | $41 |
| Metoprolol | 43 | $1,126 | $26 |
| Ezetimibe | 14 | $1,068 | $76 |
| Nitroglycerin | 21 | $542 | $26 |
| Bisoprolol | 13 | $495 | $38 |
| Carvedilol | 23 | $342 | $15 |
| Amlodipine Besylate | 37 | $334 | $9 |
| Pravastatin | 17 | $279 | $16 |
| Valsartan | 11 | $275 | $25 |
| Losartan | 18 | $231 | $13 |
| Hydrochlorothiazide | 25 | $195 | $8 |
| Lisinopril | 17 | $150 | $9 |
2022: 18 drugs
| Ranolazine Er | 16 | $1,946 | $122 |
| Rosuvastatin | 33 | $1,832 | $56 |
| Nitroglycerin | 35 | $1,637 | $47 |
| Clopidogrel | 69 | $1,635 | $24 |
| Ezetimibe | 16 | $1,587 | $99 |
| Metoprolol | 51 | $1,219 | $24 |
| Isosorbide Mononitrate Er | 36 | $1,188 | $33 |
| Atorvastatin | 90 | $1,067 | $12 |
| Nifedipine Er | 14 | $988 | $71 |
| Valsartan | 17 | $689 | $41 |
| Diltiazem 24hr Er (Cd) | 31 | $640 | $21 |
| Bisoprolol | 18 | $523 | $29 |
| Amlodipine Besylate | 52 | $363 | $7 |
| Carvedilol | 23 | $310 | $13 |
| Pravastatin | 14 | $192 | $14 |
| Losartan | 21 | $147 | $7 |
| Hydrochlorothiazide | 28 | $137 | $5 |
| Lisinopril | 24 | $122 | $5 |
2021: 17 drugs
| Isosorbide Mononitrate Er | 62 | $1,909 | $31 |
| Ezetimibe | 18 | $1,823 | $101 |
| Atorvastatin | 95 | $1,804 | $19 |
| Ranolazine Er | 11 | $1,578 | $143 |
| Rosuvastatin | 31 | $1,534 | $49 |
| Clopidogrel | 71 | $1,189 | $17 |
| Metoprolol | 45 | $1,003 | $22 |
| Diltiazem 24hr Er (Cd) | 29 | $843 | $29 |
| Amlodipine Besylate | 67 | $671 | $10 |
| Nitroglycerin | 28 | $621 | $22 |
| Bisoprolol | 21 | $550 | $26 |
| Valsartan | 11 | $444 | $40 |
| Carvedilol | 16 | $376 | $23 |
| Losartan | 21 | $364 | $17 |
| Hydrochlorothiazide | 29 | $188 | $6 |
| Lisinopril | 32 | $122 | $4 |
| Furosemide | 16 | $100 | $6 |
2020: 19 drugs
| Nitroglycerin | 41 | $2,424 | $59 |
| Isosorbide Mononitrate Er | 72 | $1,987 | $28 |
| Atorvastatin | 97 | $1,568 | $16 |
| Rosuvastatin | 27 | $1,455 | $54 |
| Clopidogrel | 86 | $1,287 | $15 |
| Ezetimibe | 11 | $1,141 | $104 |
| Diltiazem 24hr Er (Cd) | 15 | $980 | $65 |
| Amlodipine Besylate | 86 | $570 | $7 |
| Metoprolol | 24 | $473 | $20 |
| Bisoprolol | 17 | $468 | $28 |
| Warfarin | 12 | $283 | $24 |
| Carvedilol | 20 | $250 | $12 |
| Losartan | 22 | $242 | $11 |
| Benazepril | 11 | $224 | $20 |
| Olmesartan Medoxomil | 15 | $224 | $15 |
| Lisinopril | 41 | $216 | $5 |
| Furosemide | 20 | $214 | $11 |
| Hydrochlorothiazide | 22 | $184 | $8 |
| Atenolol | 15 | $84 | $6 |
2019: 17 drugs
| Xarelto | 12 | $7,184 | $599 |
| Isosorbide Mononitrate Er | 71 | $1,671 | $24 |
| Clopidogrel | 105 | $1,655 | $16 |
| Bystolic | 11 | $1,653 | $150 |
| Atorvastatin | 82 | $1,445 | $18 |
| Ezetimibe | 14 | $821 | $59 |
| Nitroglycerin | 30 | $649 | $22 |
| Metoprolol | 39 | $593 | $15 |
| Valsartan | 12 | $392 | $33 |
| Amlodipine Besylate | 68 | $391 | $6 |
| Furosemide | 27 | $245 | $9 |
| Lisinopril | 37 | $211 | $6 |
| Simvastatin | 14 | $202 | $14 |
| Carvedilol | 17 | $171 | $10 |
| Warfarin | 14 | $149 | $11 |
| Metoprolol | 14 | $104 | $7 |
| Losartan-Hydrochlorothiazide | 17 | $97 | $6 |
2018: 17 drugs
| Clopidogrel | 122 | $1,994 | $16 |
| Isosorbide Mononitrate Er | 60 | $1,680 | $28 |
| Atorvastatin | 70 | $1,004 | $14 |
| Ezetimibe | 14 | $751 | $54 |
| Metoprolol | 41 | $677 | $17 |
| Valsartan | 11 | $507 | $46 |
| Pravastatin | 13 | $392 | $30 |
| Nitroglycerin | 20 | $335 | $17 |
| Simvastatin | 17 | $243 | $14 |
| Warfarin | 23 | $240 | $10 |
| Amlodipine Besylate | 33 | $226 | $7 |
| Furosemide | 33 | $199 | $6 |
| Lisinopril | 30 | $176 | $6 |
| Carvedilol | 14 | $174 | $12 |
| Losartan | 11 | $123 | $11 |
| Metoprolol | 20 | $103 | $5 |
| Losartan-Hydrochlorothiazide | 15 | $81 | $5 |
2017: 16 drugs
| Ezetimibe | 12 | $2,302 | $192 |
| Clopidogrel | 117 | $2,216 | $19 |
| Isosorbide Mononitrate Er | 59 | $1,536 | $26 |
| Atorvastatin | 71 | $1,253 | $18 |
| Metoprolol | 28 | $857 | $31 |
| Pravastatin | 18 | $384 | $21 |
| Warfarin | 24 | $355 | $15 |
| Nitroglycerin | 19 | $341 | $18 |
| Furosemide | 40 | $268 | $7 |
| Lisinopril | 36 | $196 | $5 |
| Amlodipine Besylate | 30 | $181 | $6 |
| Metoprolol | 24 | $155 | $6 |
| Simvastatin | 18 | $153 | $9 |
| Losartan-Hydrochlorothiazide | 19 | $137 | $7 |
| Pantoprazole | 15 | $137 | $9 |
| Carvedilol | 12 | $110 | $9 |
2016: 21 drugs
| Bystolic | 14 | $4,216 | $301 |
| Clopidogrel | 176 | $3,430 | $19 |
| Atorvastatin | 104 | $2,182 | $21 |
| Isosorbide Mononitrate Er | 68 | $1,752 | $26 |
| Metoprolol | 54 | $1,382 | $26 |
| Bisoprolol | 29 | $1,062 | $37 |
| Valsartan | 13 | $985 | $76 |
| Nitrostat | 27 | $728 | $27 |
| Amlodipine Besylate | 50 | $548 | $11 |
| Lisinopril | 52 | $378 | $7 |
| Warfarin | 25 | $344 | $14 |
| Pravastatin | 14 | $324 | $23 |
| Carvedilol | 21 | $238 | $11 |
| Simvastatin | 28 | $213 | $8 |
| Metoprolol | 28 | $206 | $7 |
| Losartan | 23 | $176 | $8 |
| Furosemide | 19 | $145 | $8 |
| Pantoprazole | 17 | $143 | $8 |
| Ranitidine | 16 | $129 | $8 |
| Atenolol | 12 | $128 | $11 |
| Losartan-Hydrochlorothiazide | 18 | $126 | $7 |
2015: 22 drugs
| Bystolic | 27 | $5,362 | $199 |
| Spiriva | 11 | $3,477 | $316 |
| Atorvastatin | 91 | $2,574 | $28 |
| Clopidogrel | 172 | $2,541 | $15 |
| Valsartan | 16 | $1,997 | $125 |
| Metoprolol | 46 | $1,619 | $35 |
| Nitrostat | 50 | $1,079 | $22 |
| Isosorbide Mononitrate Er | 49 | $992 | $20 |
| Amlodipine Besylate | 43 | $850 | $20 |
| Bisoprolol | 29 | $708 | $24 |
| Simvastatin | 32 | $247 | $8 |
| Carvedilol | 28 | $236 | $8 |
| Furosemide | 35 | $231 | $7 |
| Verapamil Er | 16 | $229 | $14 |
| Lisinopril | 33 | $227 | $7 |
| Ranitidine | 23 | $227 | $10 |
| Losartan | 30 | $173 | $6 |
| Spironolactone | 13 | $158 | $12 |
| Metoprolol | 23 | $132 | $6 |
| Atenolol | 13 | $121 | $9 |
| Diltiazem 24hr Cd | 11 | $114 | $10 |
| Losartan-Hydrochlorothiazide | 12 | $80 | $7 |
2014: 18 drugs
| Bystolic | 24 | $4,419 | $184 |
| Clopidogrel | 102 | $3,316 | $33 |
| Metoprolol | 46 | $1,846 | $40 |
| Atorvastatin | 78 | $1,739 | $22 |
| Isosorbide Mononitrate Er | 38 | $1,183 | $31 |
| Bisoprolol | 28 | $1,040 | $37 |
| Amlodipine Besylate | 40 | $693 | $17 |
| Diltiazem 24hr Er | 18 | $663 | $37 |
| Nitrostat | 31 | $493 | $16 |
| Simvastatin | 34 | $371 | $11 |
| Lisinopril | 33 | $280 | $8 |
| Carvedilol | 31 | $240 | $8 |
| Metoprolol | 35 | $234 | $7 |
| Losartan | 26 | $187 | $7 |
| Ranitidine | 16 | $162 | $10 |
| Furosemide | 31 | $145 | $5 |
| Indapamide | 14 | $129 | $9 |
| Hydrochlorothiazide | 17 | $57 | $3 |
2013: 18 drugs
| Clopidogrel | 77 | $6,493 | $84 |
| Atorvastatin | 73 | $3,704 | $51 |
| Metoprolol | 58 | $1,929 | $33 |
| Isosorbide Mononitrate Er | 40 | $1,025 | $26 |
| Simvastatin | 55 | $553 | $10 |
| Toprol Xl | 13 | $528 | $41 |
| Amlodipine Besylate | 62 | $507 | $8 |
| Losartan | 23 | $363 | $16 |
| Metoprolol | 36 | $308 | $9 |
| Carvedilol | 21 | $306 | $15 |
| Nitrostat | 26 | $293 | $11 |
| Lisinopril | 32 | $188 | $6 |
| Atenolol | 14 | $125 | $9 |
| Levothyroxine | 12 | $109 | $9 |
| Furosemide | 19 | $103 | $5 |
| Indapamide | 14 | $101 | $7 |
| Ranitidine | 12 | $92 | $8 |
| Hydrochlorothiazide | 12 | $64 | $5 |
Money from drug and device companies
$56,597 in 2025
| 2025 | 4 | 59 | $43,800 | $56,597 |
| 2024 | 3 | 55 | $40,500 | $50,568 |
| 2023 | 7 | 54 | $23,725 | $45,619 |
| 2022 | 5 | 43 | $16,763 | $22,329 |
| 2021 | 4 | 30 | $9,300 | $11,139 |
| 2020 | 3 | 38 | $17,725 | $22,554 |
| 2019 | 4 | 38 | $7,200 | $22,013 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $46,094 | 48 payments
|
| Boston Scientific | General - Balloons | $8,916 | 9 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Xl Vvcs 10-12f | $1,500 | 1 payment
|
| Abbott Laboratories | Proclaim | $87 | 1 payment
|
See all 59 published payments
| Medtronic | Consulting · 2025-12-15 | Symplicity G3 | $9,425 |
| Medtronic | Travel · 2025-12-10 | Symplicity G3 | $226 |
| Medtronic | Travel · 2025-12-05 | Symplicity G3 | $203 |
| Medtronic | Travel · 2025-12-04 | Symplicity G3 | $106 |
| Medtronic | Travel · 2025-12-04 | Symplicity G3 | $12 |
| Medtronic | Consulting · 2025-11-14 | Symplicity G3 | $975 |
| Medtronic | Consulting · 2025-11-12 | Symplicity G3 | $1,625 |
| Medtronic | Travel · 2025-11-08 | Symplicity G3 | $34 |
| Medtronic | Travel · 2025-11-07 | Symplicity G3 | $616 |
| Cardiva Medical | Consulting · 2025-10-08 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $1,500 |
| Medtronic | Meals · 2025-10-06 | Symplicity G3 | $47 |
| Medtronic | Consulting · 2025-08-06 | Symplicity G3 | $650 |
| Abbott Laboratories | Meals · 2025-07-28 | Proclaim | $87 |
| Medtronic | Paid to speak or teach · 2025-07-24 | Symplicity G3 | $4,750 |
| Medtronic | Consulting · 2025-06-25 | Symplicity G3 | $1,000 |
| Medtronic | Paid to speak or teach · 2025-06-25 | Symplicity G3 | $1,250 |
| Medtronic | Travel · 2025-06-16 | None | $395 |
| Medtronic | Travel · 2025-06-13 | None | $558 |
| Medtronic | Meals · 2025-05-31 | Symplicity G3 | $69 |
| Medtronic | Meals · 2025-05-31 | Symplicity G3 | $27 |
| Medtronic | Meals · 2025-05-30 | Cardiosight Reader | $11 |
| Medtronic | Meals · 2025-05-29 | Symplicity G3 | $58 |
| Boston Scientific | Consulting · 2025-05-22 | General - Balloons | $625 |
| Boston Scientific | Consulting · 2025-05-22 | General - Balloons | $6,875 |
| Boston Scientific | Meals · 2025-05-22 | Accolade Sr | $75 |
| Boston Scientific | Travel · 2025-05-22 | Accolade Sr | $76 |
| Medtronic | Travel · 2025-05-11 | None | $313 |
| Medtronic | Meals · 2025-05-10 | None | $93 |
| Medtronic | Meals · 2025-05-10 | None | $61 |
| Medtronic | Meals · 2025-05-10 | None | $43 |
| Medtronic | Meals · 2025-05-10 | None | $123 |
| Medtronic | Travel · 2025-05-10 | None | $15 |
| Medtronic | Travel · 2025-05-09 | None | $336 |
| Medtronic | Travel · 2025-05-09 | None | $289 |
| Medtronic | Travel · 2025-05-09 | None | $46 |
| Medtronic | Travel · 2025-05-08 | None | $289 |
| Medtronic | Travel · 2025-05-08 | None | $46 |
| Medtronic | Meals · 2025-04-23 | Onyx Frontier | $23 |
| Medtronic | Travel · 2025-04-11 | None | $6,293 |
| Medtronic | Travel · 2025-04-11 | None | $56 |
| Boston Scientific | Meals · 2025-04-05 | Avvigo Guidance System | $219 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $540 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $240 |
| Boston Scientific | Meals · 2025-04-04 | Avvigo Guidance System | $231 |
| Boston Scientific | Meals · 2025-04-03 | Avvigo Guidance System | $33 |
| Medtronic | Consulting · 2025-03-28 | Symplicity G3 | $1,000 |
| Medtronic | Meals · 2025-03-08 | Onyx Frontier | $10 |
| Medtronic | Consulting · 2025-02-25 | Symplicity G3 | $9,625 |
| Medtronic | Paid to speak or teach · 2025-02-11 | None | $3,000 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $54 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $64 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $12 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $77 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $27 |
| Medtronic | Travel · 2025-02-06 | Symplicity G3 | $277 |
| Medtronic | Travel · 2025-02-05 | Symplicity G3 | $199 |
| Medtronic | Travel · 2025-02-05 | Symplicity G3 | $39 |
| Medtronic | Meals · 2025-02-05 | Symplicity G3 | $147 |
| Medtronic | Paid to speak or teach · 2025-01-30 | Symplicity G3 | $1,500 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $50,568
| Medtronic | Symplicity G3 | $50,253 | 53 payments
|
| Abiomed | Impella | $173 | 1 payment
|
| Boston Scientific | None | $141 | 1 payment
|
2023: $45,619
| Medtronic | Resolute Onyx | $35,257 | 41 payments
|
| GE HealthCare | None | $8,311 | 1 payment
|
| Boston Scientific | None | $1,530 | 5 payments
|
| Abbott Laboratories | Diamondback Coronary | $210 | 3 payments
|
| Ablative Solutions | None | $148 | 1 payment
|
| Siemens Medical Solutions USA | Artis Icono Floor | $130 | 1 payment
|
| Lexicon Pharmaceuticals | Inpefa | $32 | 2 payments
|
2022: $22,329
| Medtronic | Cardioblate | $20,261 | 29 payments
|
| Philips Electronics North America | (6399) Angio Ifr | $1,511 | 4 payments
|
| Abbott Laboratories | Mitraclip | $336 | 8 payments
|
| Ablative Solutions | None | $139 | 1 payment
|
| Boston Scientific | General - Structural Heart | $82 | 1 payment
|
2021: $11,139
| Medtronic | Resolute | $6,988 | 24 payments
|
| Boston Scientific | General Therapies | $2,400 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $1,500 | 2 payments
|
| Ablative Solutions | None | $251 | 2 payments
|
2020: $22,554
| Medtronic Vascular | Resolute | $14,765 | 26 payments
|
| Boston Scientific | General - Structural Heart | $5,379 | 9 payments
|
| Abbott Laboratories | Xience V Coronary Stent System | $2,409 | 3 payments
|
2019: $22,013
| Philips Electronics North America | Igt Systems Und | $11,384 | 6 payments
|
| Medtronic Vascular | Confida | $10,446 | 30 payments
|
| Abbott Laboratories | Mitra Clip System | $160 | 1 payment
|
| Acist Medical Systems | Cvi Consumables | $23 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic, Inc. · Spyral Affirm · 2024 | Their institution | $1,647,198 |
| Medtronic, Inc. · Spyral Affirm · 2025 | Their institution | $995,764 |
| Medtronic Vascular, Inc. · Spyral Htn-Off Med · 2019 | Their institution | $608,483 |
| Medtronic Vascular, Inc. · Spyral Htn-Off Med · 2020 | Their institution | $555,559 |
| Medtronic, Inc. · Spyral Htn-on Med · 2022 | Their institution | $318,992 |
| Medtronic, Inc. · Spyral Dystal · 2021 | Their institution | $281,576 |
| Medtronic, Inc. · Spyral Htn-on Med · 2021 | Their institution | $188,909 |
| Medtronic, Inc. · Spyral Htn-on Med Expan · 2022 | Their institution | $122,311 |
| Medtronic Vascular, Inc. · Spyral Dystal · 2020 | Their institution | $77,965 |
| Medtronic Vascular, Inc. · Spyral Htn-on Med · 2020 | Their institution | $67,983 |
| Medtronic Vascular, Inc. · Onyx One Clear · 2020 | Their institution | $66,225 |
| Medtronic Vascular, Inc. · Spyral Htn-on Med · 2019 | Their institution | $62,760 |
| Medtronic, Inc. · Spyral Htn-on Med · 2023 | Their institution | $60,532 |
| Medtronic, Inc. · Spyral Htn-Off Med · 2022 | Their institution | $60,249 |
| Medtronic, Inc. · Spyral Dystal · 2022 | Their institution | $45,136 |
| Medtronic Vascular, Inc. · Apollo Trial · 2020 | Their institution | $41,041 |
| Medtronic, Inc. · Spyral Htn-Off Med · 2021 | Their institution | $40,415 |
| Medtronic, Inc. · Spyral Htn-on Med · 2024 | Their institution | $36,932 |
| Medtronic, Inc. · Spyral Htn-on Med · 2025 | Their institution | $29,673 |
| Medtronic, Inc. · Spyral Dystal · 2024 | Their institution | $27,770 |
| Medtronic, Inc. · Spyral Htn-Off Med · 2024 | Their institution | $27,458 |
| Medtronic, Inc. · Spyral Htn-Off Med · 2023 | Their institution | $16,529 |
| Medtronic Vascular, Inc. · Onyx One Clear · 2019 | Their institution | $13,869 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study · 2019 | Their institution | $12,301 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study · 2020 | Their institution | $9,996 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study (Pfo Pas) · 2024 | Their institution | $9,062 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study (Pfo Pas) · 2022 | Their institution | $8,234 |
| Medtronic Vascular, Inc. · The Intrepid Tmvr Pilot S · 2019 | This clinician | $7,625 |
| Medtronic, Inc. · Onyx One Clear · 2022 | Their institution | $7,173 |
| Medtronic, Inc. · Onyx One Clear · 2025 | Their institution | $6,997 |
| Medtronic, Inc. · Onyx One Clear · 2021 | Their institution | $5,807 |
| Medtronic Vascular, Inc. · The Intrepid Tmvr Pilot S · 2020 | This clinician | $3,750 |
| Abbott Laboratories · Nct03309332--Amplatzer Pfo Occluder Post Approval Study · 2025 | Their institution | $3,584 |
| Medtronic, Inc. · Apollo Trial · 2021 | Their institution | $3,320 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study · 2023 | Their institution | $3,149 |
| Abbott Laboratories · Amplatzer Pfo Occluder Post Approval Study · 2021 | Their institution | $2,490 |
| Medtronic, Inc. · Spyral Htn-Off Med · 2025 | Their institution | $1,780 |
| Medtronic, Inc. · Onyx One Clear · 2024 | Their institution | $1,772 |
| Medtronic Vascular, Inc. · Symplicity Htn-3 · 2020 | Their institution | $886 |
| Medtronic, Inc. · Spyral Affirm · 2023 | Their institution | $644 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619003860
- Licence
- CA G79800California G79800: Current · expires 2028-01-31
- Trained
- University of Minnesota Medical School, 1992
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G798000
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-02-24
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.